Not provided
Not provided
Not provided
Not provided
Not provided
Funding issues
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
KISSING DEBBIE's aim at assessing angiographic and clinical outcomes of provisional treatment of coronary bifurca6on lesions according to TAP sten6ng with BMS and final kissing DEB
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Coronary bifurcation lesions |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Kissing DEB | Procedure | Provisional bare metal stenting followed by kissing drug-eluting balloons |
|
| Measure | Description | Time Frame |
|---|---|---|
| Late lumen loss on both MV and SB | 9 months |
| Measure | Description | Time Frame |
|---|---|---|
| Procedural success (residual stenosis <20% on MV and <50% on SB with TIMI flow 3 for both) | immediate | |
| Binary restenosis rate | 9 months | |
| Major adverse cardiac events |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All coming
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| UOC Emodinamica e Cardiologia Interventistica - Ospedale Santa Maria Goretti | Latina | 04100 | Italy |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 21273144 | Derived | Sgueglia GA, Todaro D, Bisciglia A, Conte M, Stipo A, Pucci E. Kissing inflation is feasible with all second-generation drug-eluting balloons. Cardiovasc Revasc Med. 2011 Sep-Oct;12(5):280-5. doi: 10.1016/j.carrev.2010.12.001. Epub 2011 Jan 26. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003324 | Coronary Artery Disease |
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| 3 months |
| Major adverse cardiac events | 6 months |
| Major adverse cardiac events | 9 months |
| Major adverse cardiac events | 12 months |
| D001161 |
| Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |
| D014652 | Vascular Diseases |